[摘要] 目的 探讨阿托伐他汀与丹红注射液联合治疗椎-基底动脉硬化致脑供血不足的临床疗效。 方法 收集2012年1月～2013年12月，我院收治的椎-基底动脉硬化致脑供血不足患者64例，随机分为观察组与对照组，各32例。两组均以常规西医治疗，对照组加用阿托伐他汀和盐酸氟桂利嗪治疗，观察组加用阿托伐他汀和丹红注射液治疗，比较两组的临床疗效。 结果 观察组的总有效率为100%，显著高于对照组的62.5%(P<0.05)；治疗后观察组的左侧椎动脉、右侧椎动脉及基底动脉的最大血流速度均显著高于对照组(P<0.05)；观察组的不良反应率为3.13%，显著低于对照组的12.50%(P<0.05)。 结论 阿托伐他汀与丹红注射液联合治疗椎-基底动脉硬化致脑供血不足可有效改善脑部血供，缓解临床症状，提高临床疗效，不良反应少，值得推广应用。

    [关键词] 脑供血不足；椎-基底动脉硬化；阿托伐他汀；丹红注射液

    [中图分类号] R743.3 [文献标识码] B [文章编号] 2095-0616(2015)19-100-03

    [Abstract] Objective To investigate the clinical efficacy of atorvastatin combined with Danhong injection in treatment of cerebral insufficiency caused by vertebral-basilar arteriosclerosis. Methods 64 patients with cerebral insufficiency caused by vertebral - basilar arteriosclerosis in our hospital between January 2012 and December 2013 were collected and randomly divided into observation group and control group32 cases in each group.The two groups received conventional Western treatment ......